2021 Highlights

Montefiore Einstein Cardiology

As challenging as 2021 was, Montefiore Einstein Cardiology made impressive strides in research, medical innovation and care. In addition to the many lifesaving procedures we performed, we broadened our footprint by establishing new outpatient and specialty clinics and contributing important scientific studies. 


2021 by the numbers

See why 2021 was a remarkable year for us
Explore the numbers


Patients admitted and successfully treated for acute myocardial infarction, congestive heart failure and/or cardiac arrhythmias


Percutaneous coronary interventions


Pacemaker and defibrillator procedures


Heart transplants

Innovations and achievements

Pioneering the future of treatment and care

A multidisciplinary approach to the management of complex cardiometabolic disorders

Dr. Leandro Slipczuk (Cardiac Imaging and Lipid Metabolism), in collaboration with Dr. Molly Fisher (Nephrology), Dr. Sasa Vukelic (Heart Failure and Transplant) and David Carruthers (Endocrinology), leads a program that provides treatment for hundreds of patients with complex disorders of lipid metabolism, uncontrolled diabetes or kidney disease, and who have or are at risk for cardiovascular disease.

One of the busiest STEMI programs in the US

Together with the routine use of intracoronary imaging and the latest technologies to approach complex intracoronary lesions, such as intravascular lithotripsy, our management of one of the country’s busiest ST-elevation myocardial infarction (STEMI) programs allows our patients to undergo complete myocardial revascularization with excellent outcomes and noticeable improvement in their quality of life.

A faculty dedicated to research and education

In 2021, we transmitted more than 100 live grand round lectures. Our faculty participated in over 50 national and international meetings and published more than 200 original articles in peer-reviewed journals.

Research Review

Improving care and outcomes through research

In 2021, we published over 200 scientific articles across a variety of topics.

Clinical Trials

Advancing care through clinical trials

In 2021, our department participated in over 30 active clinical trials. Through our management of one of the busiest STEMI programs in the US, along with our routine use of intracoronary imaging and the latest technologies—such as intravascular lithotripsy—to approach complex intracoronary lesions, our patients are able to undergo complete myocardial revascularization with excellent outcomes and noticeable improvement in their quality of life.

The Early Feasibility Study of the Transcatheter Tricuspid Valve Replacement System Transfemoral System

Clinical Trial to Evaluate Cardiovascular Outcomes in Patients Treated with the Tricuspid Valve Repair System Pivotal

Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL

Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device

ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR

Recent investments in our state-of-the-art facilities

We expanded our footprint, opening Montefiore Einstein Advanced Care - Westchester and new outpatient clinics at White Plains Hospital, Wakefield Campus and Montefiore Heart Failure Center at Nyack Hospital. We are also finalizing plans for a comprehensive heart failure initiative, which will include specialty clinics for amyloid, sarcoid, hypertrophic cardiomyopathy and pulmonary hypertension, cardiac intensive care consultations at Nyack Hospital and a new catheterization laboratory. This initiative marks a major step toward solidifying Montefiore’s footprint and heart failure expertise in New York’s Hudson Valley region.

Cast your vote

Polls on Doximity close soon. We hope you’ll consider nominating Montefiore Einstein Cardiology for the U.S. News & World Report Best Hospitals survey.